Meridian Bioscience (VIVO) Reports In-Line Q2 EPS, Beats on Revenues; Boosts FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 2.36 -0.24 (9.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.60 | 52 Week High | $21.49 | |||
| Open | $2.45 | 52 Week Low | $15.75 | |||
| Day High | $2.54 | P/E | 2.68 | |||
| Day Low | $2.30 | EPS | $0.88 | |||
| Volume | 637,745 | |||||
